Chikkanna Umesh, Venkatram Shivakumar, Holla Bharath, Mahale Rohan R, Bhargav Hemant, Jasti Lakshmi Nishitha, Ramakrishna Kishore Kumar, Varambally Shivarama
Department of Integrative Medicine, National Institute of Mental Health and Neurosciences, Bengaluru, IND.
Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, IND.
Cureus. 2025 Oct 6;17(10):e93992. doi: 10.7759/cureus.93992. eCollection 2025 Oct.
Parkinson's Disease (PD) is a protracted and progressive neurodegenerative disorder, bearing a notable semblance to the Ayurvedic construct of (trembling or shaking, often meaning a neurological disorder such as PD). This comprehensive review endeavours to offer insight into the Ayurvedic comprehension of PD and subsequently appraise the available clinical literature, explicitly investigating the utilization of Ayurvedic approaches in PD management. The methodology involved scrutinizing classical Ayurveda texts and meticulously examining pertinent scientific databases, including PubMed, Google Scholar, and the AYUSH Research Portal. This quest employed MeSH (Medical Subject Headings) terms and keywords to identify clinical trials employing Ayurvedic medicine/therapy as an intervention within the context of PD. The eligibility encompassed clinical trials published from January 2000 to December 2020; exclusions comprised review articles, conceptual papers, editorials, and studies published in languages other than English. A total of 126 studies were screened for selection criteria, and seven were included after removing duplicates. Among the seven included studies, six showed the beneficial effects of an herb called , either as a stand-alone or in combination with other herbs, and one trial highlighted the significance of bio-cleansing along with . Duration of intervention ranged from assessment of acute effects to 56 weeks. The synthesis of the reviewed data showed that exhibited an extended ON state, effectively ameliorating motor symptoms even among individuals afflicted with advanced PD while manifesting a favourable side effect profile. Nonetheless, it is imperative for future investigations to scrutinize Ayurvedic interventions in concordance with classical texts, incorporating longer follow-up periods and objective parameters to enhance the comprehensiveness and rigor of the evidence base for Ayurvedic interventions for PD.
帕金森病(PD)是一种迁延性的进行性神经退行性疾病,与阿育吠陀医学体系中“(颤抖,通常指如帕金森病这样的神经系统疾病)”的概念有显著相似之处。这篇综述旨在深入探讨阿育吠陀医学对帕金森病的理解,并随后评估现有的临床文献,特别研究阿育吠陀方法在帕金森病管理中的应用。研究方法包括仔细研读阿育吠陀经典文本,并详细审查相关科学数据库,包括PubMed、谷歌学术和阿育吠陀、瑜伽与顺势疗法部研究门户网站。这项研究使用医学主题词表(MeSH)术语和关键词来识别在帕金森病背景下将阿育吠陀药物/疗法作为干预措施的临床试验。纳入标准为2000年1月至2020年12月发表的临床试验;排除标准包括综述文章、概念性论文、社论以及非英文发表的研究。总共筛选了126项研究以符合选择标准,去除重复项后纳入了7项研究。在纳入的7项研究中,6项显示一种名为 的草药单独使用或与其他草药联合使用具有有益效果,1项试验强调了生物净化与 一起的重要性。干预持续时间从急性效应评估到56周不等。综述数据的综合分析表明, 呈现出延长的“开”期,即使在晚期帕金森病患者中也能有效改善运动症状,同时显示出良好的副作用特征。尽管如此,未来的研究必须根据经典文本仔细审查阿育吠陀干预措施,纳入更长的随访期和客观参数,以增强帕金森病阿育吠陀干预措施证据基础的全面性和严谨性。